Charles River Laboratories International (CRL) Other financing activities (2009 - 2025)

Charles River Laboratories International's Other financing activities history runs 16 years deep, the most recent figure standing at -$1.3 million for Q4 2025.

• In Q4 2025, Other financing activities rose 70.61% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at -$14.0 million (up 55.4% YoY), while the FY2025 annual figure was -$14.0 million, up 55.4% from the prior year.
• Other financing activities was -$1.3 million for Q4 2025 at Charles River Laboratories International, up from -$6.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $40.6 million in Q3 2021 to a low of -$15.5 million in Q2 2022.
• Historically, Other financing activities has averaged -$1.3 million across 5 years, with a median of -$2.3 million in 2021.
• The sharpest annual moves came in 2022 and 2025: Other financing activities tumbled 85750.0% in 2022, then surged 70.61% in 2025.
• A 5-year view of Other financing activities shows it stood at $2000.0 in 2021, then sank by 85750.0% to -$1.7 million in 2022, then tumbled by 141.97% to -$4.1 million in 2023, then dropped by 9.58% to -$4.5 million in 2024, then soared by 70.61% to -$1.3 million in 2025.
• The last three Other financing activities figures came in at -$1.3 million (Q4 2025), -$6.2 million (Q3 2025), and -$6.5 million (Q2 2025), per Business Quant data.